HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 4,430.00
-5.00 (-0.11%)
At close: Feb 13, 2026
HYUNDAI BIOLAND Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Other Revenue | - | - | - | - | -0 | - |
| 129,680 | 119,519 | 96,720 | 99,154 | 102,802 | 88,899 | |
Revenue Growth (YoY) | 15.99% | 23.57% | -2.46% | -3.55% | 15.64% | -16.38% |
Cost of Revenue | 73,618 | 66,832 | 57,191 | 63,792 | 65,808 | 71,769 |
Gross Profit | 56,062 | 52,687 | 39,529 | 35,361 | 36,994 | 17,130 |
Selling, General & Admin | 31,131 | 27,174 | 18,640 | 17,044 | 16,680 | 16,648 |
Research & Development | 7,463 | 7,300 | 6,171 | 7,470 | 7,935 | 7,236 |
Amortization of Goodwill & Intangibles | 223.87 | 262.18 | 280.37 | 281.49 | 258.34 | 118.42 |
Other Operating Expenses | 497.1 | 572.19 | 243.6 | 445.67 | 417.52 | 576.68 |
Operating Expenses | 40,456 | 36,361 | 26,101 | 26,306 | 26,336 | 25,992 |
Operating Income | 15,606 | 16,326 | 13,428 | 9,055 | 10,658 | -8,861 |
Interest Expense | -491.29 | -501.55 | -550.69 | -1,277 | -1,334 | -1,108 |
Interest & Investment Income | 768.78 | 863.21 | 970.19 | 466.02 | 185.78 | 164.44 |
Earnings From Equity Investments | - | - | - | - | - | -1,820 |
Currency Exchange Gain (Loss) | 1,851 | 2,229 | 296.32 | 291.18 | 590.04 | -77.81 |
Other Non Operating Income (Expenses) | -636.95 | -224.31 | 94.95 | 4.23 | 92.74 | -355.04 |
EBT Excluding Unusual Items | 17,098 | 18,693 | 14,239 | 8,540 | 10,192 | -12,059 |
Gain (Loss) on Sale of Investments | 19.89 | 50.81 | -461.97 | -186.82 | -306.29 | -17 |
Gain (Loss) on Sale of Assets | 39.52 | 14.46 | 2,154 | 144.09 | -772.91 | 28.28 |
Asset Writedown | -2,882 | -2,874 | 1,515 | -1,653 | -24,278 | -5,874 |
Pretax Income | 14,275 | 15,884 | 17,446 | 6,844 | -15,165 | -17,921 |
Income Tax Expense | 1,836 | 3,573 | 3,601 | 2,080 | -3,479 | -4,376 |
Earnings From Continuing Operations | 12,440 | 12,311 | 13,845 | 4,764 | -11,686 | -13,545 |
Earnings From Discontinued Operations | -15,579 | -6,607 | -5,788 | - | - | - |
Net Income | -3,139 | 5,703 | 8,056 | 4,764 | -11,686 | -13,545 |
Net Income to Common | -3,139 | 5,703 | 8,056 | 4,764 | -11,686 | -13,545 |
Net Income Growth | - | -29.21% | 69.09% | - | - | - |
Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | 30 |
Shares Change (YoY) | -0.05% | - | - | - | - | - |
EPS (Basic) | -104.67 | 190.10 | 268.54 | 158.81 | -389.54 | -451.51 |
EPS (Diluted) | -104.67 | 190.10 | 268.54 | 158.81 | -389.54 | -451.51 |
EPS Growth | - | -29.21% | 69.09% | - | - | - |
Free Cash Flow | 15,766 | 957.38 | -179.4 | 7,530 | 19,215 | 2,918 |
Free Cash Flow Per Share | 525.65 | 31.91 | -5.98 | 250.99 | 640.48 | 97.27 |
Dividend Per Share | 35.000 | 35.000 | - | - | - | - |
Gross Margin | 43.23% | 44.08% | 40.87% | 35.66% | 35.98% | 19.27% |
Operating Margin | 12.03% | 13.66% | 13.88% | 9.13% | 10.37% | -9.97% |
Profit Margin | -2.42% | 4.77% | 8.33% | 4.81% | -11.37% | -15.24% |
Free Cash Flow Margin | 12.16% | 0.80% | -0.18% | 7.59% | 18.69% | 3.28% |
EBITDA | 20,946 | 22,845 | 19,728 | 15,383 | 19,219 | -2,886 |
EBITDA Margin | 16.15% | 19.11% | 20.40% | 15.51% | 18.70% | -3.25% |
D&A For EBITDA | 5,340 | 6,518 | 6,301 | 6,328 | 8,561 | 5,976 |
EBIT | 15,606 | 16,326 | 13,428 | 9,055 | 10,658 | -8,861 |
EBIT Margin | 12.03% | 13.66% | 13.88% | 9.13% | 10.37% | -9.97% |
Effective Tax Rate | 12.86% | 22.50% | 20.64% | 30.39% | - | - |
Advertising Expenses | - | 2,802 | 222.68 | 321.77 | 502.01 | 581.27 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.